Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study
| Autor: | Manuel García-Cenoz, L Etxebarriarteun-Aranzabal, Francisco Pozo, Tomás Vega, D Castrillejo, R Sancho, J Giménez, Esteban Martínez, Carmen Quiñones, Angela Domínguez García, J M Vanrell, Inmaculada Casas, Concha Delgado-Sanz, Amparo Larrauri, S De Mateo, Silvia Jiménez-Jorge, Jesús Castilla |
|---|---|
| Přispěvatelé: | Instituto de Salud Carlos III, World Health Organization (WHO/OMS) |
| Rok vydání: | 2014 |
| Předmět: |
Adult
Male Adolescent Epidemiology Influenza vaccine Population Young Adult Influenza A Virus H1N1 Subtype Age groups Virology Influenza Human Outcome Assessment Health Care Humans Medicine Young adult Child education Aged Aged 80 and over education.field_of_study business.industry Influenza A Virus H3N2 Subtype Vaccination Public Health Environmental and Occupational Health Case-control study Infant virus diseases Middle Aged Logistic Models Influenza Vaccines Spain Virus type Case-Control Studies Child Preschool Population Surveillance Female business |
| Zdroj: | Scopus-Elsevier Repisalud Instituto de Salud Carlos III (ISCIII) |
| ISSN: | 1560-7917 |
| DOI: | 10.2807/1560-7917.es2014.19.9.20727 |
| Popis: | Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: -11 to 72), 36% (95% CI: -64 to 75) and 42% (95% CI: -29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses. This work was supported from the Influenza A(H1N1)pdm09 Programme of the Carlos III Institute of Health (GR09/0017 and PS12/00087). The GR09/0017 received additional funding from the World Health Organization Regional Office for Europe (WHO/Europe)/United States CDC (Centers for Disease Control and Prevention) and Epiconcept. Sí |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|